InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
55%
T+90 mean return
-11.7%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Danziger Asaf, Chairman & CEO. Officer active across 1 company, notably NovoCure Ltd. Aggregated, 12 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €707k. History available since 6 July 2021. The latest transaction was disclosed on 31 December 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
268 sharesOrdinary SharesSEC:0001654435-26-000003:0
412 shares@ US$14.7480.6% of flowOrdinary SharesSEC:0001562180-25-000065:0
1,239 shares@ US$12.241.3% of flowOrdinary SharesSEC:0001562180-24-006041:0
367 shares@ US$35.281.1% of flowOrdinary SharesSEC:0001562180-23-005755:0
25,000 shares@ US$11.4625.6% of flowOrdinary SharesSEC:0001645113-23-000007:0
276 shares@ US$59.0751.5% of flowOrdinary SharesSEC:0001645113-22-000062:0
31 shares@ US$63.8180.0001% mcap0.2% of flowOrdinary SharesSEC:0001645113-22-000004:0
31 shares@ US$63.8180.2% of flowOrdinary SharesSEC:0001645113-22-000004
3,870 shares@ US$102.360.024% mcap47.9% of flowOrdinary SharesSEC:0001645113-21-000116:0
Ideal exit: 23 Aug 2022 (T+270)
3,870 shares@ US$102.3633.5% of flowOrdinary SharesSEC:0001645113-21-000116
Ideal exit: 23 Aug 2022 (T+270)
118 shares@ US$137.1221.3% of flowOrdinary SharesSEC:0001645113-21-000084
118 shares@ US$137.1220.0009% mcap1.9% of flowOrdinary SharesSEC:0001645113-21-000084:0
12 of 12 declarations
About Danziger Asaf
Asaf Danziger serves as Chief Executive Officer of NovoCure Ltd. In this role, he is responsible for the overall direction of the company and the implementation of its strategy. Asaf Danziger oversees all operations and ensures that NovoCure meets its growth objectives. His leadership is essential in guiding the company in the healthcare sector.
